PhagePro is an early-stage biotechnology therapeutics company.
PhagePro has raised $200K in total funding. The most recent round was Grant. The last funding was announced in May 2025.
PhagePro's investors include National Institutes of Health, Massachusetts Life Sciences Center, MassVentures.
PhagePro is headquartered in Boston, United States.
PhagePro is an early-stage biotechnology therapeutics company.
PhagePro is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PhagePro — Funding & Investors." VCBacked, May 16, 2025, https://www.vcbacked.co/company/phagepro. Accessed July 20, 2026.
VCBacked. (2025). PhagePro — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/phagepro
{{cite web |title=PhagePro — Funding & Investors |url=https://www.vcbacked.co/company/phagepro |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated